Lawyers Claim Sam Bankman-Fried Requires Additional Adderall for Trial Concentration

Lawyers for FTX co-founder Sam Bankman-Fried have requested that he be allowed to take long-release Adderall, an ADHD medication, during his criminal trial as he has been struggling to concentrate properly. Bankman-Fried's defense case is approaching, and his lawyers are concerned that he won't be able to participate effectively without medication. They have asked the court to either stop the trial for a day if he cannot take the medication or allow him to have his prescription at the District Court. Bankman-Fried has a history of major depressive disorder and ADHD and has been under psychiatric care since early 2019.